Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

25,565 signal articles · 39 in last 24h · 122,512 total before filter · latest 46m ago
39last 24h
1244last 7d
205● bullish (7d)
149● bearish (7d)
205publishers
AllMacro210Earnings418M&A98Regulatory24Product8Analyst10
✕ clear all filterssentiment: bullishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
This Space Stock Will Beat SpaceX to the Nasdaq-100 — And It’s the One to Buy
24/7 Wall St.64d agobullish
This Space Stock Will Beat SpaceX to the Nasdaq-100 — And It’s the One to Buy

Space investing is entering a new phase. SpaceX‘s (NASDAQ:SPCX) blockbuster IPO quickly became the largest and one of the most anticipated public listings in market history, prompting the Nasdaq exchange to revise its inclusion rules to speed the company’s path into its major indexes. Those rule changes will likely accomplish their goal. SpaceX appears on ... This Space Stock Will Beat SpaceX to the Nasdaq-100 — And It’s the One to Buy

NXP Semiconductors (NXPI) Draws Fresh Fund Interest As Buybacks Return
Simply Wall St.64d agobullish
NXP Semiconductors (NXPI) Draws Fresh Fund Interest As Buybacks Return

Institutional investors and hedge funds have recently increased long positions in NXP Semiconductors, NasdaqGS:NXPI. This follows the reopening of key trade routes such as the Strait of Hormuz and improving macroeconomic conditions. Management has outlined plans to resume share buybacks in the upcoming quarter, signaling a renewed focus on shareholder returns. NXP Semiconductors enters this phase of renewed interest with the stock trading around $313.27 and strong multi year returns,...

Wall Street Technician Declares Financials, Industrials, and Biotech Poised for Breakouts. 3 ETFs Could Soar.
24/7 Wall St.64d agobullish
Wall Street Technician Declares Financials, Industrials, and Biotech Poised for Breakouts. 3 ETFs Could Soar.

Markets are hunting for new leadership as the Big Tech engine sputters, and one Wall Street technician thinks she knows where the baton is being passed. On CNBC’s Closing Bell Overtime, Fairlead Strategies founder Katie Stockton argued that financials, industrials, and biotech look ready to take over leadership as semiconductor and memory names show their ... Wall Street Technician Declares Financials, Industrials, and Biotech Poised for Breakouts. 3 ETFs Could Soar.

XRP ETFs vs. HYPE ETFs: Which Is the Better Buy Right Now?
24/7 Wall St.64d agobullish
XRP ETFs vs. HYPE ETFs: Which Is the Better Buy Right Now?

A year ago, you couldn’t buy either of these cryptocurrencies in a normal brokerage account. Now, both XRP (CRYPTO:XRP) and Hyperliquid have spot ETFs trading on U.S. exchanges, both coins rank among the top 10, and if you want regulated exposure to one of them, you have to pick a side. However, deciding the best ... XRP ETFs vs. HYPE ETFs: Which Is the Better Buy Right Now?

Enphase Energy (ENPH) Stock Could Be 14.3% Overvalued After Barclays Upgrade
Simply Wall St.64d agobullish
Enphase Energy (ENPH) Stock Could Be 14.3% Overvalued After Barclays Upgrade

Enphase Energy (ENPH) is back in focus after Barclays upgraded the stock, citing its emerging solid state transformer business for data centers and new IQ9S-3P Commercial Microinverter shipments in the U.S. See our latest analysis for Enphase Energy. The Barclays upgrade and new IQ9S-3P Commercial Microinverter shipments come after a mixed stretch for Enphase Energy, with the 30-day share price return down 16.14% but the year-to-date share price return still up 54.90% and the 1-year total...

Centene (CNC) Stock Could Be 11.1% Overvalued After Employee Buyout Plan
Simply Wall St.64d agobullish
Centene (CNC) Stock Could Be 11.1% Overvalued After Employee Buyout Plan

Centene (CNC) has drawn fresh attention after launching a voluntary buyout program for most employees, in response to a substantial drop in health plan membership tied to expiring federal pandemic subsidies and higher consumer costs. See our latest analysis for Centene. At a share price of $61.02, Centene has seen a 77.38% 90 day share price return and a 46.05% year to date share price return, while the 5 year total shareholder return has declined 17.43%. This suggests strong recent momentum...